DUBLIN, Jan. 24, 2022 /PRNewswire/ — The “North America Legal Cannabis Market Size, Share & Trends Analysis Report by Sources (Marijuana, Hemp), by Derivatives (CBD, THC), by End Use (Medical, Recreational), and Segment Forecasts, 2022-2028” report has been added to ResearchAndMarkets.com’s providing.
The North America authorized hashish market measurement is predicted to achieve USD 38.2 billion by 2028, registering a CAGR of 16.6% from 2022 to 2028. The rising legalization and rising use of marijuana for medical functions are anticipated to propel market progress.
As well as, as nations within the area are actively liberalizing legal guidelines associated to marijuana, the market is more likely to witness elevated demand for cannabis-based merchandise in addition to their derivatives. The marijuana section dominated the market in 2021. The upper effectivity of marijuana-derived CBD is among the essential components signifying the bigger share of this section.
The section can be projected to develop on the quickest CAGR throughout the forecast interval. The CBD section dominated the market in 2021 as a result of rising consciousness concerning the optimistic results of CBD for the therapy of varied medical situations, comparable to power ache, most cancers & a number of sclerosis. In 2021, the leisure section dominated the market.
The legalization of marijuana for grownup use has pushed the product demand within the leisure use utility section. In nations, comparable to Canada and the U.S., the place marijuana for leisure use has been legalized, the market has witnessed a dynamic shift of sufferers from conventional strategies or drugs to opting to make use of marijuana for medical and different functions.
This may be attributed to the simple availability and low pricing. Furthermore, a rise within the choice for Cannabidiol (CBD)-based merchandise, comparable to meals & drinks, cosmetics, and wellness merchandise within the nation helps market progress. Canada is anticipated to register the quickest progress fee throughout the forecast interval.
Rising hashish cultivation, the emergence of native gamers, favorable authorities initiatives, and growing adoption of cannabis-based merchandise are a number of the key components supporting the market progress within the nation. The COVID-19 pandemic has considerably affected the market.
The provision chain disruptions and interruption within the transportation of hashish & associated uncooked supplies, on account of nationwide lockdown within the U.S. & Canada, hampered the market progress. As well as, panic-buying situations in these nations throughout the preliminary months of the pandemic led to a scarcity in product shares, thereby widening the demand-supply hole.
Nonetheless, with conditions heading towards normalcy, the cannabis-based product gross sales and the availability chain within the North American area are anticipated to stabilize and develop throughout the forecast interval.
North America Authorized Hashish Market Report Highlights
- The market is anticipated to have important progress over the forecast interval owing to rising legalization and rising use of marijuana for medical functions
- The marijuana section dominated the market in 2021 owing to the rising adoption of marijuana merchandise together with the growing legalization of medical marijuana
- In 2021, the CBD section accounted for the very best income share owing to the growing adoption of CBD for numerous medical functions and rising consciousness about affirmative results of CBD for the therapy of varied medical situations
- The leisure utility section accounted for the very best income share, owing to components comparable to elevated adoption of hashish for leisure functions and altering shopper conduct towards the usage of hashish
- The U.S. is anticipated to be the most important market by 2028 owing to numerous components, comparable to excessive consciousness about cannabis-based merchandise, the introduction of the 2018 Farm Invoice that legalized hemp-derived merchandise within the nation, and a rise within the choice for Cannabidiol (CBD)-based merchandise
Key Subjects Coated:
Chapter 1 Methodology and Scope
Chapter 2 Government Abstract
Chapter 3 North America Authorized Hashish Market: Variables, Traits & Scope
3.1 Market Segmentation
3.2 Penetration & Progress Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Evaluation
3.3.1.1 Rising adoption of medical marijuana for therapy of power ailments
3.3.1.2 Elimination of black market by way of the legalization of medical marijuana
3.3.2 Market Restraint Evaluation
3.3.2.1 Excessive pricing of hashish in comparison with unlawful markets within the U.S.
3.3.2.2 Illicit hashish commerce as a result of surplus cultivation
3.4 Business Evaluation-SWOT Evaluation, By Issue (Political & Authorized, Financial, And Technological
3.5 Hashish Market-Porter’s Evaluation
3.6 Historical past of Medical Use of Hashish in North America
3.7 Historical past of Industrial Use of Hashish in North America
3.8 North America Authorized Hashish Variety of scientific trials
3.9 Authorized Hashish Business: Legalization Timeline in North America
3.9.1 Legalization Panorama (Timeline)
3.9.2 The U.S. Legalization Panorama
3.9.3 The Canada Legalization Panorama
3.9.4 North America Authorized Hashish Regulatory State of affairs, By Nation
3.10 North America Authorized Hashish Business: Consumption Sample Evaluation
3.11 Commerce Alternative Evaluation, by area
3.12 Authorized Hashish Business: Nation Case Examine
3.12.1 U.S.
3.12.1.1 Legalization of Hashish
3.12.1.2 Purpose for Legalization
3.12.1.3 State of affairs After Legalization and Client Perspective
3.12.1.4 Aggressive Panorama Publish Legalization
3.12.2 Canada
3.13 Human Abuse Legal responsibility Expertise in North America Hashish Market
3.14 Qualitative evaluation on artificial cannabinoids and hashish in North America
Chapter 4 North America Authorized Hashish Market: Supply Sort Estimates & Pattern Evaluation
4.1 North America Authorized Hashish Market: Supply Sort Motion Evaluation
4.2 North America Authorized Hashish Market: Supply Sort Evaluation
4.2.1 Hemp
4.2.1.1 Hemp Market Estimates and Forecasts, 2016-2028 (USD Million)
4.2.1.2 Hemp CBD
4.2.1.3 Dietary supplements
4.2.1.4 Industrial Hemp
4.2.2 Marijuana
4.2.2.1 Marijuana Market Estimates and Forecasts, 2016-2028 (USD Million)
4.2.2.2 Flower
4.2.2.3 Oils and Tinctures
Chapter 5 North America Authorized Hashish Market: Derivatives Sort Estimates & Pattern Evaluation
5.1 North America Authorized Hashish Market: Derivatives Sort Motion Evaluation
5.2 North America Authorized Hashish Market: Derivatives Sort Evaluation
5.2.1 CBD
5.2.2 THC
5.2.3 Others
Chapter 6 North America Authorized Hashish Market: Finish-use Estimates & Pattern Evaluation
6.1 North America Authorized Hashish Market: Finish Use Motion Evaluation
6.2 North America Authorized Hashish Market: Finish Use Evaluation
6.2.1 Leisure Use
6.2.2 Medical Use
6.2.2.1 Medical Use Market Estimates and Forecasts, 2016-2028 (USD Million)
6.2.2.2 Persistent Ache
6.2.2.3 Most cancers
6.2.2.4 Despair and Nervousness
6.2.2.5 Arthritis
6.2.2.6 Diabetes
6.2.2.7 Glaucoma
6.2.2.8 Migraines
6.2.2.9 Epilepsy
6.2.2.10 A number of Sclerosis
6.2.2.11 AIDS
6.2.2.12 Amyotrophic Lateral Sclerosis (ALS)
6.2.2.13 Alzheimer’s
6.2.2.14 Publish Traumatic Stress Dysfunction (PTSD)
6.2.2.15 Parkinson’s
6.2.2.16 Tourette’s
6.2.2.17 Others
6.2.3 Industrial Use
6.2.3.1 Textile
6.2.3.2 Non-Textile
Chapter 7 North America Authorized Hashish Market: Regional Estimates & Pattern Evaluation
7.1 North America Authorized Hashish Market: Area Motion Evaluation, 2016-2028
Chapter 8 Aggressive Evaluation
8.1 Firm Market Place Evaluation
8.2 Latest Developments & Influence Evaluation, By Key Market Contributors
8.3 Firm/Competitors Categorization (Key Innovators, Market Leaders, Rising Gamers)
8.4 Listing of Tobacco Firms Investing in Hashish
Chapter 9 Aggressive Panorama
- Cover Progress Company
- GW Prescribed drugs, plc
- Aurora Hashish
- Aphria, Inc. (Previous to the merger with Tilray)
- Cronos Group
- Tilray
- Sundial Growers
- Insys Therapeutics, Inc.
- Vivo Hashish Inc.
- Cara Therapeutics, Inc
For extra details about this report go to https://www.researchandmarkets.com/r/hisbz1
Media Contact:
Analysis and Markets
Laura Wooden, Senior Supervisor
[email protected]
For E.S.T Workplace Hours Name +1-917-300-0470
For U.S./CAN Toll Free Name +1-800-526-8630
For GMT Workplace Hours Name +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (exterior U.S.): +353-1-481-1716
SOURCE Analysis and Markets
